Who is Dr. Daniel P. Huttenlocher and why was he appointed?

Dr. Daniel P. Huttenlocher is a new director appointed to Corning's Board. His appointment, recommended by the Nominating and Corporate Governance Committee, is expected to enhance the Board's expertise and oversight capabilities, particularly with his placement on the Audit and Finance committees.

What is the significance of Richard T. Clark's re-election as Lead Independent Director?

Richard T. Clark's re-election as Lead Independent Director signifies continued confidence in his leadership and experience. As the former CEO of Merck, his ongoing role as Lead Independent Director provides valuable strategic guidance and ensures independent oversight of the Board's activities.

Are there any financial implications or changes to Corning's business operations reported in this 8-K?

No, this specific 8-K filing does not report any changes to Corning's financial performance or business operations. It exclusively pertains to board-level governance changes, specifically the appointment of a new director and the re-election of the Lead Independent Director.

What does it mean that Dr. Huttenlocher qualified as independent and had no related party transactions?

This means Dr. Huttenlocher does not have any direct or indirect financial or personal relationships with Corning Incorporated that could interfere with his independent judgment as a director. It ensures his objectivity in board decisions and fulfills a key requirement for independent directors on audit committees.

GLW 8-K: Leadership Changes

Summary

Corning Incorporated (GLW) filed an 8-K on February 3, 2015, to report the appointment of Dr. Daniel P. Huttenlocher to its Board of Directors. Dr. Huttenlocher was nominated by the Nominating and Corporate Governance Committee and subsequently appointed to the Audit Committee and the Finance Committee. The company confirmed he had no related party transactions and qualified as an independent director. Additionally, the Board re-elected Richard T. Clark as Lead Independent Director, effective February 4, 2015. Mr. Clark, the former Chairman, CEO, and President of Merck & Co., Inc., has been a member of Corning's Board since 2011. These appointments are routine governance updates intended to strengthen the Board's composition and oversight.

Key Highlights

1Dr. Daniel P. Huttenlocher appointed to the Board of Directors.
2Dr. Huttenlocher appointed to the Audit Committee and Finance Committee.
3Dr. Huttenlocher meets independence requirements and has no related party transactions.
4Richard T. Clark re-elected as Lead Independent Director, effective February 4, 2015.
5Mr. Clark brings extensive leadership experience from his tenure at Merck & Co., Inc.
6The filing is considered a routine governance update by the company.

CORNING INC /NY 8-K Report, Executive Changes (Feb 4, 2015)

Summary

Key Highlights

Frequently Asked Questions